Welcome to our dedicated page for CN Healthy Food Tech Group SEC filings (Ticker: UCFI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CN Healthy Food Tech Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CN Healthy Food Tech Group's regulatory disclosures and financial reporting.
CN Healthy Food Tech Group Corp. is a Delaware holding company whose China-based subsidiaries develop, manufacture, and sell AI-driven, biotech health foods using grain-based and traditional Chinese medicine ingredients. The group operates an 18,000-square-meter production base in Heilongjiang and sells through over 10,000 offline specialty stores plus major Chinese e-commerce and social platforms.
The company completed a SPAC merger on September 30, 2025 and was renamed CN Healthy Food Tech Group Corp., with its stock and warrants listed on Nasdaq under “UCFI” and “UCFIW.” On October 1, 2025, Nasdaq halted trading after China’s securities regulator indicated its review of the U.S. listing was not complete, and trading has not resumed.
Management highlights significant risks from the trading halt, potential Nasdaq delisting, stringent PRC regulations over overseas listings, data and cybersecurity rules, and China’s evolving legal environment. As of March 31, 2026, 52,234,983 shares of common stock were outstanding. The company has not paid dividends and relies on China subsidiaries for upstreaming cash, subject to PRC profit, reserve, tax, and FX constraints.